Does ENZALUTAMIDE Cause Oedema peripheral? 401 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 401 reports of Oedema peripheral have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.8% of all adverse event reports for ENZALUTAMIDE.
401
Reports of Oedema peripheral with ENZALUTAMIDE
0.8%
of all ENZALUTAMIDE reports
55
Deaths
105
Hospitalizations
How Dangerous Is Oedema peripheral From ENZALUTAMIDE?
Of the 401 reports, 55 (13.7%) resulted in death, 105 (26.2%) required hospitalization, and 7 (1.7%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 401 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which ENZALUTAMIDE Alternatives Have Lower Oedema peripheral Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE